| Epidemiology, prevention, and management of influenza in patients with hematologic malignancy. | |
| | |
MedLine Citation:
|
PMID: 21303339 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Influenza results in annual epidemics of respiratory viral illness during the winter; when a novel virus enters the human population, a pandemic may result with a larger proportion of the population sickened. Unlike the mild and typically self-limited disease seen in immunocompetent patients, immunocompromised patients frequently have a more severe course. These individuals shed virus for a prolonged period of time, have a high rate of viral pneumonia, more frequently develop bacterial and fungal super-infections, and may develop late-onset airflow obstruction. Further, antiviral resistance develops more frequently in immunosuppressed patients. Although the cornerstone of prevention of influenza is vaccination, vaccine efficacy in patients with hematologic malignancies, particularly stem cell transplant recipients, is poor. Alternative preventative measures, such as seasonal antiviral prophylaxis can be considered. Lastly, there have been no prospective studies of antivirals in the management of influenza infections in these patients. As such, the optimal regimen and duration remains to be defined. Available evidence suggests that prolonged course are frequently needed. Patients who fail to response or have relapsed infections should be tested for emergence of antiviral resistance and alternative diagnoses should be investigated. |
| | |
Authors:
|
Michael G Ison |
Related Documents
:
|
23386999 - Burkholderia vaccines: are we moving forward? 23151169 - Optimizing efficacy of mucosal vaccines. 23622679 - Effects of vaccine program against pandemic influenza a(h1n1) virus, united states, 200... 23375979 - Oral immunization of a live attenuated escherichia coli strain expressing a holotoxin-s... 23449269 - Effectiveness of influenza vaccine for preventing laboratory-confirmed influenza hospit... 23206409 - Immunoproteomics selection of cross-protective vaccine candidates from riemerella anati... 11599079 - Tuning compounds for electrospray ionization/in-source collision-induced dissociation a... 12921389 - Monitoring the stability of human vaccines. 21612239 - Conjugation of lipid and cpg-containing oligonucleotide yields an efficient method for ... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Infectious disorders drug targets Volume: 11 ISSN: 1871-5265 ISO Abbreviation: Infect Disord Drug Targets Publication Date: 2011 Feb |
Date Detail:
|
Created Date: 2011-02-09 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101269158 Medline TA: Infect Disord Drug Targets Country: United Arab Emirates |
Other Details:
|
Languages: eng Pagination: 34-9 Citation Subset: IM |
Affiliation:
|
Divisions of Infectious Diseases, 645 N. Michigan Avenue Suite 900, Chicago, Illinois 60611, USA. mgison@northwestern.edu. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Epidemiology and prevention of viral infections in patients with hematologic malignancies.
Next Document: Infection and anemia.